|
Real-time Estimate
Cboe BZX
04:16:21 06/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 21.40 USD | -0.33% |
|
+3.37% | -19.66% |
| 01:54am | Acadia Pharmaceuticals Sees Continued Daybue Momentum in Q3, RBC Says | MT |
| 12:12am | RBC Raises Price Target on ACADIA Pharmaceuticals to $38 From $36, Keeps Outperform Rating | MT |
| Market Cap | 3.7B 3.3B 3.02B 2.75B 5.18B 350B 5.32B 36.22B 14.48B 185B 13.89B 13.59B 584B | P/E 2026 * |
34.8x | P/E 2027 * | 24x |
|---|---|---|---|---|---|
| Enterprise Value | 2.69B 2.4B 2.19B 2B 3.76B 254B 3.87B 26.34B 10.53B 135B 10.1B 9.88B 425B | EV / Sales 2026 * |
2.12x | EV / Sales 2027 * | 1.72x |
| Free-Float |
99.67% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ACAD | Delayed | |
CBOE
| ACAD | Real-time | |
|
Tradegate
| DR6 | Real-time | |
|
Mexican S.E.
| ACAD * | End-of-day quote | |
|
Boerse Muenchen
| DR6 | Real-time | |
|
Deutsche Boerse AG
| DR6 | Delayed | |
|
Börse Stuttgart
| DR6 | Delayed |
Last Transcript: Acadia Pharmaceuticals Inc.
| 1 day | -0.26% | ||
| 1 week | +3.37% | ||
| Current month | +4.23% | ||
| 1 month | +6.71% | ||
| 3 months | -25.49% | ||
| 6 months | -3.98% | ||
| Current year | -19.66% |
| 1 week | 20.25 |  | 22.63 |
| 1 month | 18.39 | | 22.63 |
| Current year | 18.39 | | 30.96 |
| 1 year | 18.39 | | 30.96 |
| 3 years | 13.4 | | 32.59 |
| 5 years | 12.24 | | 33.99 |
| 10 years | 12.24 | | 58.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Catherine Adams
CEO | Chief Executive Officer | 55 | 20/09/2024 |
Mark Schneyer
DFI | Director of Finance/CFO | 52 | 10/09/2021 |
Scott Cenci
CTO | Chief Tech/Sci/R&D Officer | - | 04/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Laura Brege
BRD | Director/Board Member | 68 | 01/05/2008 |
Stephen Biggar
CHM | Chairman | 55 | 10/06/2016 |
Edmund Harrigan
BRD | Director/Board Member | 73 | 25/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/8/26 | Exercice | Chief Financial Officer | 42,876 | 0.0250% | ||
| 30/7/26 | Sell | Chief Technology Officer | -16,558 | 0.0097% | ||
| 29/5/26 | Exercice | Director | 41,529 | 0.0243% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.33% | +3.37% | -3.90% | -10.51% | 3.7B | |
| +3.80% | +8.47% | +64.65% | +77.70% | 66.87B | |
| +1.63% | +4.93% | +24.89% | +102.90% | 56.55B | |
| +0.07% | +1.39% | +12.75% | +76.61% | 57.2B | |
| +0.14% | -3.78% | +25.96% | +33.40% | 43.47B | |
| -9.81% | -3.46% | +209.54% | +752.74% | 42.8B | |
| +3.15% | +5.18% | +21.60% | +99.25% | 42.95B | |
| +1.59% | -4.04% | +97.66% | +81.57% | 32.11B | |
| +7.50% | +13.28% | +28.05% | +64.46% | 34.01B | |
| -2.41% | -3.62% | -42.45% | +351.15% | 24.13B | |
| Average | +0.56% | +4.15% | +43.88% | +162.93% | 40.38B | |
| Weighted average by Cap. | +0.81% | +3.93% | +50.86% | +164.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.27B 1.13B 1.04B 944M 1.78B 120B 1.83B 12.46B 4.98B 63.66B 4.77B 4.67B 201B | 1.43B 1.27B 1.17B 1.06B 2B 135B 2.06B 14.01B 5.6B 71.58B 5.37B 5.25B 226B |
| Net income | 108M 96.49M 88.26M 80.38M 152M 10.23B 156M 1.06B 424M 5.42B 406M 398M 17.1B | 162M 144M 132M 120M 226M 15.27B 232M 1.58B 633M 8.09B 607M 594M 25.52B |
| Net Debt | -1.01B -899M -822M -749M -1.41B -95.35B -1.45B -9.88B -3.95B -50.5B -3.79B -3.71B -159B | -1.24B -1.1B -1.01B -918M -1.73B -117B -1.78B -12.11B -4.84B -61.91B -4.64B -4.54B -195B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | US$21.45 | -0.12% | 4,663,061 |
| 04/11/26 | US$21.47 | +4.38% | 4,719,961 |
| 03/11/26 | US$20.57 | +0.49% | 1,709,205 |
| 02/11/26 | US$20.47 | -0.58% | 1,384,944 |
| 30/10/26 | US$20.59 | -0.82% | 1,137,497 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACAD Stock
Select your edition
All financial news and data tailored to specific country editions
